site logo

J&J readies rivals to da Vinci and Mako, eyeing new markets for robots

The medtech won't begin marketing its orthopaedics platform until 2021, with general surgery offering Ottava a few years behind, but its Monarch robot targeting lung cancer continues to gain ground.

Johnson & Johnson